- Home
- REPL vs BRKL Comparison
REPL vs BRKL Comparison
Compare REPL & BRKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- BRKL
- Stock Information
- Founded
- REPL 2015
- BRKL 1871
- Country
- REPL United States
- BRKL United States
- Employees
- REPL N/A
- BRKL N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- BRKL Savings Institutions
- Sector
- REPL Health Care
- BRKL Finance
- Exchange
- REPL Nasdaq
- BRKL Nasdaq
- Market Cap
- REPL 757.8M
- BRKL 897.3M
- IPO Year
- REPL 2018
- BRKL 1998
- Fundamental
- Price
- REPL $9.35
- BRKL $10.60
- Analyst Decision
- REPL Strong Buy
- BRKL Buy
- Analyst Count
- REPL 7
- BRKL 2
- Target Price
- REPL $20.83
- BRKL $15.25
- AVG Volume (30 Days)
- REPL 1.1M
- BRKL 560.7K
- Earning Date
- REPL 08-07-2025
- BRKL 07-23-2025
- Dividend Yield
- REPL N/A
- BRKL 5.08%
- EPS Growth
- REPL N/A
- BRKL N/A
- EPS
- REPL N/A
- BRKL 0.82
- Revenue
- REPL N/A
- BRKL $338,567,000.00
- Revenue This Year
- REPL N/A
- BRKL $53.95
- Revenue Next Year
- REPL N/A
- BRKL $68.33
- P/E Ratio
- REPL N/A
- BRKL $12.95
- Revenue Growth
- REPL N/A
- BRKL N/A
- 52 Week Low
- REPL $6.44
- BRKL $8.35
- 52 Week High
- REPL $17.00
- BRKL $13.15
- Technical
- Relative Strength Index (RSI)
- REPL 49.55
- BRKL 55.13
- Support Level
- REPL $8.92
- BRKL $10.31
- Resistance Level
- REPL $9.93
- BRKL $10.61
- Average True Range (ATR)
- REPL 0.52
- BRKL 0.22
- MACD
- REPL -0.08
- BRKL 0.03
- Stochastic Oscillator
- REPL 22.40
- BRKL 80.52
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About BRKL Brookline Bancorp Inc.
Brookline Bancorp Inc operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.